Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1991;83:1437-1443

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hale, S. L.
Right arrow Articles by Kloner, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hale, S. L.
Right arrow Articles by Kloner, R. A.

Circulation, Vol 83, 1437-1443, Copyright © 1991 by American Heart Association


ARTICLES

Nifedipine protects the heart from the acute deleterious effects of cocaine if administered before but not after cocaine

SL Hale, KJ Alker, SH Rezkalla, AC Eisenhauer and RA Kloner
Heart Institute, Hospital of the Good Samaritan, Los Angeles, CA 90017.

BACKGROUND. We tested the hypothesis that nifedipine, a calcium channel blocker, could ameliorate the toxic effects of cocaine on the myocardium. METHODS AND RESULTS. In an initial protocol, anesthetized dogs were pretreated with nifedipine or saline and then administered cocaine (10 mg/kg, i.v. bolus). Coronary blood flow, heart rate, mean arterial pressure, and the first derivation of left ventricular pressure (dP/dt) were measured at baseline, 2 minutes, and 15 minutes after cocaine administration. Nifedipine pretreatment prevented the early cocaine-induced decrease in coronary blood flow and improved left ventricular dP/dt compared with untreated control animals. After cocaine, ejection fraction fell in the saline group to 37 +/- 3% but increased in the nifedipine group to 59 +/- 4% (p less than 0.05). In a second protocol, vehicle or intravenous nifedipine was administered after an infusion of cocaine (10 mg/kg). In contrast to pretreatment, there was no significant improvement in left ventricular function or coronary blood flow in nifedipine-treated versus control animals. Data from the study also suggested that cocaine acts directly on the myocardium. Within seconds of cocaine bolus administration, coronary blood flow in control animals increased to a peak level 59 +/- 14% higher than before cocaine and left ventricular dP/dt decreased by 23 +/- 5%, providing evidence that cocaine causes direct depression of myocardial function independent of a decrease in myocardial blood flow. CONCLUSIONS. We conclude that nifedipine administered as a pretreatment protects against the depression of myocardial function and decrease in coronary blood flow caused by acute cocaine administration. However, when nifedipine is given after cocaine, no improvement is seen. Cocaine has a direct negative inotropic effect on the heart that is independent of a decrease in coronary blood flow.


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
P. Parikh, L. A. Nikolaidis, C. Stolarski, Y.-T. Shen, and R. P. Shannon
Chronic Exposure to Cocaine Binging Predisposes to an Accelerated Course of Dilated Cardiomyopathy in Conscious Dogs following Rapid Ventricular Pacing
J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 1013 - 1019.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. P. Shannon, W. T. Manders, and Y.-T. Shen
Role of Blood Doping in the Coronary Vasoconstrictor Response to Cocaine
Circulation, July 1, 1995; 92(1): 96 - 105.
[Abstract] [Full Text]